financetom
Business
financetom
/
Business
/
Bright Green Signs Letter of Intent to Supply Marijuana Extracts, Psychedelics to Benuvia
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bright Green Signs Letter of Intent to Supply Marijuana Extracts, Psychedelics to Benuvia
Aug 21, 2024 7:22 PM

10:32 AM EDT, 08/21/2024 (MT Newswires) -- Bright Green (BGXX) said Wednesday it signed a letter of intent to supply marijuana extracts and plant-based psychedelics to Benuvia Operations.

As part of the proposed deal, Benuvia plans to produce domestically manufactured, pharmaceutical-grade active pharmaceutical ingredients for US and global markets in partnership with Bright Green, the company said.

Bright Green shares were down more than 10% in recent trading.

Price: 0.22, Change: -0.03, Percent Change: -10.55

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ligand Pharmaceuticals' Q4 Core Adjusted Net Income, Total Revenue Rise; 2025 Guidance Set
Ligand Pharmaceuticals' Q4 Core Adjusted Net Income, Total Revenue Rise; 2025 Guidance Set
Feb 27, 2025
09:25 AM EST, 02/27/2025 (MT Newswires) -- Ligand Pharmaceuticals ( LGND ) reported Q4 core adjusted net income Thursday of $1.27 per diluted share, up from $1.05 a year earlier. Analysts polled by FactSet expected $1.19. Total revenue for the quarter ended Dec. 31 was $42.8 million, up from $28.1 million a year earlier. Analysts surveyed by FactSet expected $39...
American Woodmark Fiscal Q3 Adjusted Earnings, Net Sales Down; Fiscal 2025 Net Sales Guidance Revised
American Woodmark Fiscal Q3 Adjusted Earnings, Net Sales Down; Fiscal 2025 Net Sales Guidance Revised
Feb 27, 2025
09:24 AM EST, 02/27/2025 (MT Newswires) -- American Woodmark ( AMWD ) reported fiscal Q3 adjusted earnings Thursday of $1.05 per diluted share, down from $1.56 a year earlier. Four analysts polled by FactSet expected $1.32. Net sales for the quarter ended Jan. 31 were $397.6 million, down from $422.1 million a year earlier. Four analysts surveyed by FactSet expected...
Aurinia Pharmaceuticals Swings to Q4 Earnings, Revenue Rises
Aurinia Pharmaceuticals Swings to Q4 Earnings, Revenue Rises
Feb 27, 2025
09:24 AM EST, 02/27/2025 (MT Newswires) -- Aurinia Pharmaceuticals ( AUPH ) reported Q4 earnings Thursday of $0.01 per diluted share, swinging from a loss of $0.19 a year earlier. Analysts polled by FactSet expected a loss of $0.02. Revenue for the quarter ended Dec. 31 was $59.9 million, up from $45.1 million a year earlier. Analysts surveyed by FactSet...
Amazon Web Services Debuts New Quantum Computing Chip
Amazon Web Services Debuts New Quantum Computing Chip
Feb 27, 2025
09:24 AM EST, 02/27/2025 (MT Newswires) -- Amazon.com's ( AMZN ) Amazon Web Services on Thursday unveiled Ocelot, a new quantum computing chip that it says can reduce the costs of implementing quantum error correction by as much as 90%. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved